NEW YORK ( TheStreet) -- Haemonetics Corporation (NYSE: HAE) hit a new 52-week high Monday as it is currently trading at $71.71, above its previous 52-week high of $71.50 with 48,128 shares traded as of 9:45 a.m. ET. Average volume has been 109,400 shares over the past 30 days. Haemonetics has a market cap of $1.72 billion and is part of the health care sector and health services industry. Haemonetics Corporation develops and manufactures automated blood component collection devices and surgical blood salvage devices to plasma and blood collectors, hospitals, and health care providers.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter